Acetylcysteine, also known as N-acetylcysteine (NAC), is a modified amino acid that is used as an antidote for acetaminophen overdose to prevent hepatic injury. Acetylcysteine is a hepatoprotective agent and has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.
Acetylcysteine is an efficient API for COPD and PB treatment. Also, it is added in nutritional supplements for cosmetology. Generally, acetylcysteine is mainly used to produce medicine in India and Europe. While in America, it is mainly used in nutritional supplements.
Raw material of acetylcysteine is mainly L-cysteine, which is distributed all over the world. Also manufacture process of acetylcysteine is mature. So, there are many acetylcysteine suppliers globally. Global major producers included in the report are Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo and Manus Aktteva Biopharma. Market concentration in this industry is high. In 2016, sales of those manufacturers account for 77.18% of global total sales.
Global major consumption regions are distributed in USA, Europe and India. In 2016, Europe consumed about 3908.2 MT acetylcysteine. USA and India separately consumed about 3005.4 MT and 1392.3 MT in 2016. Meanwhile, most acetylcysteine API suppliers also produce downstream medicine directly, especially most Europe and India suppliers.
The report offers detailed coverage of Acetylcysteine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Acetylcysteine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Acetylcysteine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Acetylcysteine market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Zambon
Moehs
Pharmazell
Nippon Rika
Chengyi Pharma
Wuhan Grand Hoyo
Manus Aktteva Biopharma
At the same time, we classify Acetylcysteine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Spray
Tracheal Drip
Tablet
Market by Application
Medicine
Nutritional Supplements
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Acetylcysteine market for the forecast period 2021 - 2025?
• What are the driving forces in the Acetylcysteine market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Acetylcysteine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?